Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication
Developmental Cell · 2024
DOI: 10.1016/j.devcel.2024.03.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Cell, 2024. Verfasst von Adler Guerrero Zuniga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Oncology, The …. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Whole-genome duplication (WGD) is a frequent event in cancer evolution that fuels chromosomal instability. WGD can result from mitotic errors or endoreduplication, yet the molecular mechanisms that drive WGD remain unclear. Here, we use live single-cell analysis to characterize cell-cycle dynamics upon aberrant Ras-ERK signaling. We find that sustained ERK signaling in human cells leads to reactivation of the APC/C in G2, resulting in tetraploid G0-like cells that are primed for WGD. This process is independent of DNA damage or p53 but dependent on p21. Transcriptomics analysis and live-cell imaging showed that constitutive ERK activity promotes p21 expression, which is necessary and sufficient to inhibit CDK activity and which prematurely activates the anaphase-promoting complex (APC/C). Finally, either loss of p53 or reduced ERK signaling allowed for endoreduplication, completing a WGD event. Thus, sustained ERK signaling-induced G2 cell cycle exit represents an alternative path to WGD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA;…
- Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Biomedical Engineering, The Johns Hopkins University, Baltimore, MD 21205, USA.
- Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
- National Science Foundation
Zitieren
APA
Guerrero Zuniga, A., Aikin, T. J., McKenney, C., Lendner, Y., Phung, A., Hook, P. W., Meltzer, A., Timp, W., & Regot, S. (2024). Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication. Developmental Cell. https://doi.org/10.1016/j.devcel.2024.03.032
Vancouver
Guerrero Zuniga A, Aikin TJ, McKenney C, Lendner Y, Phung A, Hook PW, et al. Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication. Developmental Cell. 2024. doi:10.1016/j.devcel.2024.03.032
BibTeX
@article{GuerreroZuniga2024,
author = {Guerrero Zuniga, Adler and Aikin, Timothy J and McKenney, Connor and Lendner, Yovel and Phung, Alain and Hook, Paul W and Meltzer, Amy and Timp, Winston and Regot, Sergi},
title = {Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication},
journal = {Developmental Cell},
year = {2024},
doi = {10.1016/j.devcel.2024.03.032}
}
EUVIMED